4766 LaGuardia Drive,
St. Louis, Montana 63134-3117
Gallus BioPharmaceuticals is a contract manufacturing company offering exceptional contract services to its clients. Gallus’ world-class facility in St. Louis is distinguished by nearly three decades of biologics development and over a decade of commercial cGMP manufacturing, including the ongoing manufacture of Remicade® and Stelara® for Janssen Pharmaceuticals.
Gallus Biopharmaceuticals was acquired by DPx Holdings BV on August 27, 2014.
Join Mergr to view all 208 acquisitions of life science companies in 2014, including 13 acquisitions by private equity firms, and 195 by strategics.
Out of 60 sectors in the Mergr database, life science ranked 12 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Gallus Biopharmaceuticals.
No obligation. Cancel anytime.